Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.
Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A, Lopez-Galvez M, Navarro-Gil R, Verges R. · 2016
Read Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory. by Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A, Lopez-Galvez M, Navarro-Gil R, Verges R. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5059543.txt.
Description
Pedro Romero-Aroca and five co-authors review diabetic macular edema in the Journal of Diabetes Research in 2016. The condition swells the center of the retina and is the leading cause of blindness in diabetic patients. Two engines are blamed: leaking blood vessels, driven by the factor VEGF, and low-grade inflammation. Whether vessel growth causes the inflammation or follows it was unresolved.
Their reading of the evidence is that the two act together, each feeding the other as the disease develops. Sugar damage breaks the blood-retina barrier and starts leakage, while inflammation switches on alongside and makes the damage chronic. About thirty percent of cases resist treatment. Both anti-VEGF drugs and steroids work, but on different arms of the disease, so knowing which arm dominates in a given patient should guide the choice. Today's scans cannot tell the two apart, a gap the authors want closed.
Catalog record
| CREATOR | Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A, Lopez-Galvez M, Navarro-Gil R, Verges R. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 73 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |